Lit Matters #3: BaSICS Trial - Rate of Fluid

In critically ill patients receiving a fluid challenge, bolus speed alone did not change 90-day mortality in the BaSICS trial. This large ICU randomized trial speaks directly to emergency and critical care questions about IV fluid rate, resuscitation strategy, and whether slower infusion improves outcomes.

BaSICS Fluid Rate Trial

• Mortality outcome signal: A slower fluid bolus rate did not improve 90-day mortality compared with a faster rate, reinforcing that infusion speed by itself is not a mortality lever in broad critical illness.
• Headline infusion rates: The trial compared 333 mL/hr versus 999 mL/hr, giving a concrete bedside definition of what the authors meant by slower and faster fluid administration.
• Large pragmatic ICU sample: More than 10,000 patients across 75 ICUs were randomized, which gives the negative primary result unusual weight for clinicians deciding how much to trust it.
• Early organ support signal: By day 3, the slower-rate group showed slightly better SOFA-related hemodynamic and respiratory findings, including less vasopressor use and less severe oxygenation failure.
• Transient secondary differences: Those early physiologic advantages were not sustained by day 7, a useful reminder that short-term organ support signals do not necessarily translate into durable patient-centered benefit. We get into why that matters in the episode.